Larimar Therapeutics, Inc.
LRMR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374690
In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Larimar Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- −4 vs. Q4 2021
- Shares held
- 15.3M
- +690.4K (+4.7%) vs. Q4 2021
- Total value
- $61.8M
- −$95.4M (−60.7%) vs. Q4 2021
- New holders
- 2
- 14 more added
- Sold out
- 6
- 11 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LRMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 163 | $291.4M |
| Q1 2026 | 162 | $394.8M |
| Q4 2025 | 136 | $277.0M |
| Q3 2025 | 136 | $274.8M |
| Q2 2025 | 116 | $180.1M |
| Q1 2025 | 103 | $131.9M |
| Q4 2024 | 116 | $245.5M |
| Q3 2024 | 123 | $421.3M |
| Q2 2024 | 107 | $473.5M |
| Q1 2024 | 104 | $482.8M |
| Q4 2023 | 69 | $179.6M |
| Q3 2023 | 65 | $153.0M |
| Q2 2023 | 65 | $120.2M |
| Q1 2023 | 69 | $174.2M |
| Q4 2022 | 48 | $160.1M |
| Q3 2022 | 59 | $123.9M |
| Q2 2022 | 40 | $28.2M |
| Q1 2022 | 45 | $61.8M |
| Q4 2021 | 49 | $157.2M |
| Q3 2021 | 54 | $167.5M |
| Q2 2021 | 45 | $142.8M |
| Q1 2021 | 57 | $206.1M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Larimar Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 46 | $0 | 0.00% | −836−94.8% | Reduced |
| Disciplined Investments, LLC | 116 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 29 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 29 | $0 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 225 | $1.00K | 0.00% | +225 | New |
| Citigroup Inc | 386 | $2.00K | 0.00% | −158−29.0% | Reduced |
| Cutler Group LP | 1,200 | $4.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 1,175 | $5.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,215 | $5.00K | 0.00% | +89+7.9% | Added |
| UBS Group AG | 1,733 | $7.00K | 0.00% | +612+54.6% | Added |
| JPMorgan Chase & Co | 2,101 | $9.00K | 0.00% | +523+33.1% | Added |
| Solstein Capital, LLC | 4,477 | $18.0K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 12,897 | $52.0K | 0.00% | +12,897 | New |
| Two Sigma Advisers, LP | 13,998 | $57.0K | 0.00% | −14,200−50.4% | Reduced |
| Bank of New York Mellon Corp | 18,973 | $77.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 21,330 | $86.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 28,138 | $114.0K | 0.00% | 00.0% | Unchanged |
| Royce & Associates LP | 28,064 | $114.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 28,412 | $115.0K | 0.00% | +9,701+51.8% | Added |
| Golden State Equity Partners | 30,415 | $123.0K | 0.06% | +5,400+21.6% | Added |
| State Street Corp | 41,450 | $168.0K | 0.00% | +2,417+6.2% | Added |
| DAFNA Capital Management LLC | 49,996 | $202.0K | 0.05% | −20,181−28.8% | Reduced |
| Ikarian Capital, LLC | 51,606 | $209.0K | 0.06% | +4,413+9.4% | Added |
| Difesa Capital Management, LP | 52,050 | $211.0K | 0.13% | −400−0.8% | Reduced |
| Susquehanna International Group, LLP | 55,366 | $224.0K | 0.00% | −43,974−44.3% | Reduced |
| Bridgeway Capital Management, LLC | 62,800 | $254.0K | 0.00% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 100,000 | $405.0K | 0.20% | −125,000−55.6% | Reduced |
| Geode Capital Management, LLC | 113,890 | $461.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 116,223 | $471.0K | 0.00% | +43,713+60.3% | Added |
| Fi3 FINANCIAL ADVISORS, LLC | 121,818 | $493.0K | 0.38% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 172,742 | $700.0K | 0.00% | −20,032−10.4% | Reduced |
| Adage Capital Partners GP, L.L.C. | 176,680 | $716.0K | 0.00% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 210,500 | $853.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 245,856 | $996.0K | 0.00% | +959+0.4% | Added |
| 683 Capital Management, LLC | 250,000 | $1.01M | 0.06% | −6,620−2.6% | Reduced |
| Atlas Venture Advisors, Inc. | 292,184 | $1.18M | 0.25% | 00.0% | Unchanged |
| Verition Fund Management LLC | 424,599 | $1.72M | 0.03% | +188,764+80.0% | Added |
| Vanguard Group Inc | 511,082 | $2.07M | 0.00% | −14,961−2.8% | Reduced |
| Morgan Stanley | 529,984 | $2.15M | 0.00% | +518,189+4,393.3% | Added |
| Mangrove Partners | 867,812 | $3.52M | 0.28% | +627,859+261.7% | Added |
| Opaleye Management Inc. | 943,702 | $3.82M | 1.19% | +60,100+6.8% | Added |
| Janus Henderson Group PLC | 1,045,245 | $4.22M | 0.00% | +310,133+42.2% | Added |
| Ra Capital Management, L.P. | 1,281,860 | $5.19M | 0.11% | −52,750−4.0% | Reduced |
| CHI Advisors LLC | 1,515,148 | $6.14M | 2.61% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 5,830,249 | $23.6M | 0.53% | 00.0% | Unchanged |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −399,830−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −196,896−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −175,870−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −11,392−100.0% | Sold out |
| Northeast Financial Consultants Inc | 0 | $0 | 0.00% | −10,105−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −2,395−100.0% | Sold out |